Home > Official notices > Statutory Committee decisions | Search
|
|
Statutory Committee decisionsSet out below are the outcomes of recent inquiries heard before the Statutory Committee of the Royal Pharmaceutical Society of Great Britain on Monday 22 January, Tuesday 23 January and Wednesday 24 January 2007. 1. Following the inquiry into a complaint by the Council of the Society
against Ramanlal Ambaram Mistry (registration number 74751) and Mistry
Pharmacy Ltd (identification number 1084440), the committee directed
the removal of Mr Mistry’s name from the Register. The committee
found proved the allegation that: dispensing to a patient atenolol tablets
labelled as amitriptyline in response to a prescription calling for amitriptyline
hydrochloride; dispensing to a patient doxazosin labelled as tolterodine
in response to a prescription calling for tolterodine; dispensing to
a patient ramipril capsules labelled as lisinopril tablets in response
to a prescription calling for lisinopril tablets; causing or permitting
atenolol tablets that had previously been dispensed to be returned to
dispensary stock; causing or permitting additional medicines that had
previously been dispensed to patients to be returned to dispensary stock;
and causing or permitting, through a failure to appoint a superintendent
pharmacist between 1 April 2000 and 4 July 2005, the company to carry
on a retail pharmacy business unlawfully during that period, amounted
to misconduct. Under Section 11 of the Pharmacy Act 1954, the direction
to remove Mr Mistry’s name from the Register is not to take effect
until the expiration of a period of three months from the date on which
notice of removal was given or in a case where an appeal has been brought
against the direction, until the appeal is determined or withdrawn. The
Committee further directed that no further action should be taken against
Mistry Pharmacy Ltd. David Gomez |